Literature DB >> 6252342

Characterization of Aleutian disease virus as a parvovirus.

M E Bloom, R E Race, J B Wolfinbarger.   

Abstract

We characterized a strain of Aleutian disease virus adapted to growth in Crandall feline kidney cells at 31.8 degrees C. When purified from infected cells, Aleutian disease virus had a density in CsCl of 1.42 to 1.44 g/ml and was 24 to 26 nm in diameter. [3H]thymidine could be incorporated into the viral genome, and the viral DNA was then studied. In alkaline sucrose gradients, Aleutian disease virus DNA was a single species that cosedimented at 15.5S with single-stranded DNA from adeno-associated virus. When the DNA was analyzed on neutral sucrose gradients, a single species was again observed, which sedimented at 21S and was clearly distinct from 16S duplex adeno-associated virus DNA. A similar result was obtained even after incubation under annealing conditions, implying that the bulk of Aleutian disease virus virions contained a single non-complementary strand with a molecular weight of about 1.4 X 10(6). In addition, two major virus-associated polypeptides with molecular weights of 89,100 and 77,600 were demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of virus purified from infected cultures labeled with [35S]methionine. These data suggest that Aleutian disease virus is a nondefective parvovirus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252342      PMCID: PMC288877     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

Review 2.  Purification and structure of aleutian disease virus.

Authors:  H J Cho
Journal:  Front Biol       Date:  1976

Review 3.  The epizootiology of aleutian disease.

Authors:  J R Gorham; J B Henson; T B Crawford; G A Padgett
Journal:  Front Biol       Date:  1976

4.  Arrangement of nucleotide sequences in adeno-associated virus DNA.

Authors:  H W Gerry; T J Kelly; K I Berns
Journal:  J Mol Biol       Date:  1973-09-15       Impact factor: 5.469

5.  Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis.

Authors:  P A Sharp; B Sugden; J Sambrook
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

6.  Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK).

Authors:  R A Crandell; C G Fabricant; W A Nelson-Rees
Journal:  In Vitro       Date:  1973 Nov-Dec

7.  Purification and ultrastructure of Aleutian disease virus of mink.

Authors:  B Chesebro; M Bloom; W Hadlow; R Race
Journal:  Nature       Date:  1975-04-03       Impact factor: 49.962

8.  The antigen and virus of Aleutian disease in mink.

Authors:  H J Cho; D G Ingram
Journal:  J Immunol Methods       Date:  1974-03       Impact factor: 2.303

9.  Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus.

Authors:  M E Bloom; R E Race; W J Hadlow; B Chesebro
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

10.  Pathogenesis of aleutian disease of mink: identification of nonpersistent infections.

Authors:  A E Larsen; D D Porter
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

View more
  62 in total

1.  Molecular comparisons of in vivo- and in vitro-derived strains of Aleutian disease of mink parvovirus.

Authors:  M E Bloom; O R Kaaden; E Huggans; A Cohn; J B Wolfinbarger
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Bocavirus infection induces mitochondrion-mediated apoptosis and cell cycle arrest at G2/M phase.

Authors:  Aaron Yun Chen; Yong Luo; Fang Cheng; Yuning Sun; Jianming Qiu
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink.

Authors:  E Gottschalck; S Alexandersen; A Cohn; L A Poulsen; M E Bloom; B Aasted
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  The transcription profile of Aleutian mink disease virus in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter.

Authors:  Jianming Qiu; Fang Cheng; Lisa R Burger; David Pintel
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Analysis of molecularly cloned DNA reveals minor differences among three virus strains of Aleutian disease of mink parvovirus. Brief report.

Authors:  M E Bloom; D Lechner; D L Wiedbrauk; J B Wolfinbarger
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Internal polyadenylation of parvoviral precursor mRNA limits progeny virus production.

Authors:  Qinfeng Huang; Xuefeng Deng; Sonja M Best; Marshall E Bloom; Yi Li; Jianming Qiu
Journal:  Virology       Date:  2012-02-21       Impact factor: 3.616

7.  Interferon response in normal and Aleutian disease virus-infected mink.

Authors:  D L Wiedbrauk; W J Hadlow; L C Ewalt; D L Lodmell
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

8.  Treatment of neonatally Aleutian disease virus (ADV) infected mink kits with gammaglobulin containing antibodies to ADV reduces the death rate of mink kits.

Authors:  B Aasted; S Alexandersen; M Hansen
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

9.  Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink.

Authors:  M E Bloom; R E Race; B Aasted; J B Wolfinbarger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation.

Authors:  M E Bloom; S M Best; S F Hayes; R D Wells; J B Wolfinbarger; R McKenna; M Agbandje-McKenna
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.